CompletedNot Applicable

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Philippines16 participantsStarted 2022-10-10

Plain-language summary

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * underwent anatomic lung resection * previous COVID-19 infection documented by nasopharyngeal swab RT-PCR or GeneXpert * with negative nasopharyngeal swab RT-PCR or GeneXpert prior to lung resection Exclusion Criteria: * with incomplete patient records

What they're measuring

Mortality rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Major complication rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Minor complication rate

Timeframe: perioperative period (within 30 days after anatomic lung resection)

Length of postoperative hospital stay

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Trial details

NCT IDNCT05513248

SponsorLung Center of the Philippines

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-31

View on ClinicalTrials.gov More COVID-19 trials